Evidence map›Paper›PMID 41514531›Full record

ArticleCancers2025

Finding the True Responders: Stratifying dMMR/MSI-H Tumors for ICI Response.

Nari Kim, Seongwon Na, Jisung Jang, Mihyun Kim, Jun Hee Pyo, Kyung Won Kim

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nari KimBiomedical Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.ORCID 0000-0001-5384-9540
Seongwon NaDepartments of Radiology and Research Institute of Radiology, Asan Medical Center, College of Medicine, University of Ulsan, Olymphic-ro 43 Gil 88, Songpa-gu, Seoul 05505, Republic of Korea.ORCID 0009-0004-9742-5351
Jisung JangTrial Informatics Inc., Seoul 05544, Republic of Korea.ORCID 0000-0001-9300-3945
Mihyun KimTrial Informatics Inc., Seoul 05544, Republic of Korea.ORCID 0009-0008-4232-7139
Jun Hee PyoConvergence AI Institute for Drug Discovery, Korea Pharmaceutical and Bio-Pharma Manufacturers Association, Seoul 06666, Republic of Korea.ORCID 0000-0002-2807-1340
Kyung Won KimBiomedical Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.ORCID 0000-0002-1532-5970

Funding

Korea Health Industry Development Institute RS-2018-KH049509National Research Foundation of Korea RS-2023-00227084
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerdMMRimmune checkpoint inhibitorsimmunogenomic stratificationMSI-Hprecision immunotherapytranscriptomic signature

Identifiers

PMID41514531
PMCPMC12784724

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.